Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2-Reference-Cited by-同舟云学术

Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2

Published:2014-03-12 Issue:5 Volume:261 Page:963-969
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Ferner Rosalie E.,Shaw Adam,Evans D. Gareth,McAleer Dympna,Halliday Dorothy,Parry Allyson,Raymond F. Lucy,Durie-Gair Juliette,Hanemann C. Oliver,Hornigold Rachel,Axon Patrick,Golding John F.

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-014-7303-1/fulltext.html

Reference19 articles.

1. Evans DG (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16

2. Evans DGR, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumour prone syndromes: estimates from a UK genetic family register service. Am J Med Genet A 152A(2):327–332

3. Ferner R (2007) Neurofibromatosis 1 and neurofibromatosis 2: a twenty-first century perspective. Lancet Neurol 6(4):340–345

4. Patel CM, Ferner R, Grunfeld EA (2011) A qualitative study of the impact of living with neurofibromatosis type 2. Psychol Health Med 16(1):19–28

5. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, De Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363(6429):515–521

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors;New England Journal of Medicine;2024-06-27

2. Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas;Hearing Research;2024-06

3. Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis;Cancers;2024-05-22

4. Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients;Neuro-Oncology;2024-05-02

5. Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma;Journal of Neuro-Oncology;2024-02-19